David S. Millan,Wei Lu,Seng-Lai Tan,Stephane Soroosh Radfar,Sailaja Battula
申请号：
US16545339
公开号：
US20190374536A1
申请日:
2019.08.20
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present disclosure relates to methods of treating, preventing or ameliorating a TH17- or CSF1-mediated disease or disorder such as cancer, immunological disorders, and obesity by administering to a patient in need thereof a therapeutically effective amount of a FASN inhibitor, or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof.
